103 related articles for article (PubMed ID: 22186363)
1. [Reactivation of hepatitis B infection due to glucocorticoids].
Ramsoekh D; Metselaar HJ; de Man RA
Ned Tijdschr Geneeskd; 2011; 155(50):A3710. PubMed ID: 22186363
[TBL] [Abstract][Full Text] [Related]
2. Risk of hepatitis B virus reactivation in patients with asthma or chronic obstructive pulmonary disease treated with corticosteroids.
Kim TW; Kim MN; Kwon JW; Kim KM; Kim SH; Kim W; Park HW; Chang YS; Cho SH; Min KU; Kim YY
Respirology; 2010 Oct; 15(7):1092-7. PubMed ID: 20630033
[TBL] [Abstract][Full Text] [Related]
3. [Reactivation of hepatitis B virus due to rituximab plus CHOP after preemptive lamivudine administration in a patient with diffuse large B-cell lymphoma].
Ono K; Iyama S; Matsunaga T; Sato T; Sato Y; Okuda T; Takada K; Kawano Y; Hayashi T; Miyanishi K; Sagawa T; Kobune M; Takimoto R; Kato J; Niitsu Y
Gan To Kagaku Ryoho; 2007 Sep; 34(9):1509-12. PubMed ID: 17876158
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.
Tseng TC; Liu CJ; Hsieh SC; Chen PJ; Lai MY; Chen DS; Kao JH
Dig Liver Dis; 2009 Apr; 41(4):322-3. PubMed ID: 18848814
[No Abstract] [Full Text] [Related]
5. Entecavir as prophylaxis against hepatitis B virus reactivation following chemotherapy for lymphoma.
Uchiyama M; Tamai Y; Ikeda T
Int J Infect Dis; 2010 Mar; 14(3):e265-6. PubMed ID: 19665406
[No Abstract] [Full Text] [Related]
6. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
7. Delayed hepatitis B virus reactivation after cessation of preemptive lamivudine in lymphoma patients treated with rituximab plus CHOP.
Dai MS; Chao TY; Kao WY; Shyu RY; Liu TM
Ann Hematol; 2004 Dec; 83(12):769-74. PubMed ID: 15338194
[TBL] [Abstract][Full Text] [Related]
8. Low incidence of hepatitis B virus reactivation during chemotherapy among diffuse large B-cell lymphoma patients who are HBsAg-negative/ HBcAb-positive: a multicenter retrospective study.
Ji D; Cao J; Hong X; Li J; Wang J; Chen F; Wang C; Zou S
Eur J Haematol; 2010 Sep; 85(3):243-50. PubMed ID: 20491883
[TBL] [Abstract][Full Text] [Related]
9. Fulminant hepatic failure due to chemotherapy-induced hepatitis B reactivation: role of rituximab.
Stange MA; Tutarel O; Pischke S; Schneider A; Strassburg CP; Becker T; Barg-Hock H; Bastürk M; Wursthorn K; Cornberg M; Ott M; Greten TF; Manns MP; Wedemeyer H
Z Gastroenterol; 2010 Feb; 48(2):258-63. PubMed ID: 20127601
[TBL] [Abstract][Full Text] [Related]
10. Risk of hepatitis B virus (HBV) reactivation in hepatitis B surface antigen negative/hepatitis B core antibody positive patients receiving rituximab-containing combination chemotherapy without routine antiviral prophylaxis.
Koo YX; Tay M; Teh YE; Teng D; Tan DS; Tan IB; Tai DW; Quek R; Tao M; Lim ST
Ann Hematol; 2011 Oct; 90(10):1219-23. PubMed ID: 21520001
[TBL] [Abstract][Full Text] [Related]
11. Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients.
Markovic S; Drozina G; Vovk M; Fidler-Jenko M
Hepatogastroenterology; 1999; 46(29):2925-30. PubMed ID: 10576374
[TBL] [Abstract][Full Text] [Related]
12. [Nucleos(t)ides as prophylaxis for the reactivation of hepatitis B virus in immunosuppressed patients].
Fan LY; Zhou Z; Zhong S; Ling N; Wang ZY; Shi XF; Zhang DZ; Ren H
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):429-33. PubMed ID: 19567021
[TBL] [Abstract][Full Text] [Related]
13. Prospective analysis of hepatitis B virus reactivation in patients with diffuse large B-cell lymphoma after rituximab combination chemotherapy.
Niitsu N; Hagiwara Y; Tanae K; Kohri M; Takahashi N
J Clin Oncol; 2010 Dec; 28(34):5097-100. PubMed ID: 20837949
[TBL] [Abstract][Full Text] [Related]
14. Systemic corticosteroid and reactivation of chronic hepatitis B.
Lai CL; Yuen MF
Respirology; 2010 Oct; 15(7):1017-8. PubMed ID: 20874743
[No Abstract] [Full Text] [Related]
15. Entecavir is an optional agent to prevent hepatitis B virus (HBV) reactivation: a review of 16 patients.
Watanabe M; Shibuya A; Takada J; Tanaka Y; Okuwaki Y; Minamino T; Hidaka H; Nakazawa T; Koizumi W
Eur J Intern Med; 2010 Aug; 21(4):333-7. PubMed ID: 20603047
[TBL] [Abstract][Full Text] [Related]
16. Chronic hepatitis B reactivation following infliximab therapy in Crohn's disease patients: need for primary prophylaxis.
Esteve M; Saro C; González-Huix F; Suarez F; Forné M; Viver JM
Gut; 2004 Sep; 53(9):1363-5. PubMed ID: 15306601
[TBL] [Abstract][Full Text] [Related]
17. A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Long M; Jia W; Li S; Jin L; Wu J; Rao N; Feng H; Chen K; Deng H; Liu F; Su F; Song E
Breast Cancer Res Treat; 2011 Jun; 127(3):705-12. PubMed ID: 21445574
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hepatitis B reactivation with lamivudine in hepatitis B virus carriers with hematologic malignancies treated with chemotherapy--a prospective case series.
Vassiliadis T; Garipidou V; Tziomalos K; Perifanis V; Giouleme O; Vakalopoulou S
Am J Hematol; 2005 Nov; 80(3):197-203. PubMed ID: 16247746
[TBL] [Abstract][Full Text] [Related]
19. Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Leaw SJ; Yen CJ; Huang WT; Chen TY; Su WC; Tsao CJ
Ann Hematol; 2004 May; 83(5):270-5. PubMed ID: 15060745
[TBL] [Abstract][Full Text] [Related]
20. [Effective treatment with Lamivudine of patients with reactivation of hepatitis B following chemotherapy administration].
Shtalrid M; Haran M; Klepfish A; Lurie Y; Malnick S
Harefuah; 2001 Dec; 140(12):1159-62, 1230, 1229. PubMed ID: 11789300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
